4502 logo

Takeda Pharmaceutical Community

TSE:4502 Community
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 24 Fair Values set on narratives written by author
Create a narrative

Community Investing Ideas

4502 logo
Takeda Pharmaceutical
AN
AnalystConsensusTarget
AnalystConsensusTarget
Consensus Narrative from 16 Analysts

Upcoming Drug Launches And Leadership Change Will Boost Future Prospects

Key Takeaways Leadership transition to Julie Kim in 2026 aligns with potential drug launches, enhancing future revenue and investor sentiment. Growth in Launch Products and late-stage pipeline developments underscore strong sales potential and earnings boost.
View narrative
JP¥4.97k
FV
15.4% undervalued intrinsic discount
0.54%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
9users have followed this narrative
1 day ago author updated this narrative